Synchronized long-read genome, methylome, epigenome, and transcriptome for resolving a Mendelian condition.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
27 Sep 2023
27 Sep 2023
Historique:
pubmed:
9
10
2023
medline:
9
10
2023
entrez:
9
10
2023
Statut:
epublish
Résumé
Resolving the molecular basis of a Mendelian condition (MC) remains challenging owing to the diverse mechanisms by which genetic variants cause disease. To address this, we developed a synchronized long-read genome, methylome, epigenome, and transcriptome sequencing approach, which enables accurate single-nucleotide, insertion-deletion, and structural variant calling and diploid
Identifiants
pubmed: 37808736
doi: 10.1101/2023.09.26.559521
pmc: PMC10557686
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIH HHS
ID : DP5 OD029630
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007454
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG010233
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006493
Pays : United States
Déclaration de conflit d'intérêts
Conflicts J.K., J.G.U., C.T.S., A.M.W., M.K. and I.J.M. are full-time employees at PacBio, a company developing single-molecule sequencing technologies. A.B.S. is a co-inventor on a patent relating to the Fiber-seq method (US17/995,058).